Description
NUCLEAR PHARMACY CONFERENCE (Technician)
Saturday, October 5, 2024
Nuclear Medicine in Pediatrics 8:00am-9:30am
Elizabeth Rhoda, PharmD, RPh, Purdue University Nuclear Pharmacy Fellow
Upon completion of this activity, participants will be able to: Recognize commonly used pediatric nuclear medicine studies and protocols; Identify pearls and considerations for pediatric use of radiopharmaceuticals; Summarize key points regarding pediatric radiobiology; Evaluate different dosing methods for pediatrics and calculate correct doses for pediatrics; Explore advantages and challenges with using PET MRI vs PET CT pediatrics.
UAN: 0675-0000-24-031-L01-T
Cancer Associated Fibroblast (CAF) and Current Clinical Trial Diagnostic Agents
9:30am-11:00am
Garcia Simon Clark, PharmD, MS, ANP, CCP, BCNP, Kindred Healthcare, Pharmacy Supervisor
Upon completion of this activity, participants will be able to: Describe fibroblast activation protein and its role in cancer; Discuss multiple cancer type detection using fibroblast labeled with a radiotracer; Evaluate the clinical trials using fibroblast detection.
UAN: 0675-0000-24-032-L01-T
PET on the Mind: Radiopharmaceuticals for Brain Imaging
11:15am-12:45pm
Elizabeth Rayes, PharmD, Brigham and Women’s Hospital Nuclear Pharmacy, RadioPharmacist
Upon completion of this activity, participants will be able to: Describe Beta-Amyloid and its role in Alzheimer's; Discuss the use of F18 Beta-Amyloid imaging agents; Evaluate clinical trials on the use of tau & microglial radiotracers.
UAN: 0675-0000-24-033-L01-T
Germanium 68/Gallium 68 Generator Best Practices
12:45pm-2:15pm
Jay Simon, RPh, ANP, Managing Director North America, Eckert & Zeigler
Upon completion of this activity, participants will be able to: Discuss the methods for production of Gallium 68 to be incorporated into a drug product; Describe the steps of eluting a GalliPharm generator and the process of measuring the Germanium 68 breakthrough; Explain best sterile techniques when eluting the gallium generator either in an ISO 8 or ISO 5 environment.
UAN: 0675-0000-24-034-L01-T
Sunday, October 6, 2024
Advancements in Pulmonary Imaging – It’s Here – Exploring Technegas
8:00am-9:30am
Vesper Grantham, MEd, RT(N), CNMT, Chair, Medical Imaging and Radiation Sciences, Program Director, Nuclear Medicine
Upon completion of this activity, participants will be able to: Describe the protocol features of Technegas including equipment, radiopharmaceutical administration, and imaging protocol; Discuss the advantages of Technegas over traditional ventilation imaging agents; Evaluate implementation of Technegas for nuclear medicine departments.
UAN: 0675-0000-24-035-L01-T
The U.S. Nuclear Regulatory Commission (NRC) Advisory Committee on the Medical Use of Isotopes (ACMUI)
9:30am - 11:00am
Richard Green, BSPharm, RPh, BCNP FAPhA,
Upon completion of this activity, participants will be able to: Discuss the ACMUI role in the NRC; Describe the current make-up of the ACMUI membership; Discuss the topics recently taken up by the ACMUI; Identify areas of future NRC action as a result of ACMUI reports.
UAN: 0675-0000-24-036-L03-T
Radiotherapeutics: Best Practice and Updates
11:15am-12:45pm
Akram Hussein, PharmD, MBA, BCNP, Director – Nuclear Medicine Radiopharmacy, MD Anderson Cancer Center
Upon completion of this activity, participants will be able to: Describe the tools and infrastructure needed for a successful radiotherapeutics program; Discuss how a commercial and hospital nuclear pharmacist can support a theranostics center; Explain medical events related to radiotherapies and how to decrease their occurrence.
UAN: 0675-0000-24-037-L01-T
Instrument Review and Best Practices for Nuclear Pharmacy
12:45pm-2:15pm
Wendy Galbraith, PharmD, FAPhA, BCNP, Clinical Associate Professor, University of Oklahoma, Dept. of Pharmaceutical Sciences, College of Pharmacy, Nuclear Pharmacy & Research Imaging Facility
Upon completion of this activity, participants will be able to: Describe National Institute of Standards and Technology primary and secondary sources; Explain the error rate in measuring activity from various radiopharmaceuticals; Describe how to change or add a new calibration setting on the dose calibrators.
UAN: 0675-0000-24-038-L01-T
